SALT LAKE CITY / Jun 05, 2023 / Business Wire / Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Healthcare Conference.
Management will participate in a fireside chat presentation on Wednesday, June 7, 2023 at 3:30pm EST. The presentation will be webcast live and may be accessed through the following link: https://wsw.com/webcast/jeff281/vrex/1883310.
A replay of the presentation will be available on Varex’s website at www.vareximaging.com/news. The replay will be available for 90 days after the presentation.
About Varex
Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate Varex’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose, protect and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,400 people located in North America, Europe, and Asia. For more information visit vareximaging.com.
Last Trade: | US$8.35 |
Daily Change: | -0.08 -0.95 |
Daily Volume: | 41,073 |
Market Cap: | US$346.610M |
February 03, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load